- Report
- April 2024
- 146 Pages
Global
From €7149EUR$7,950USD£6,166GBP
- Report
- February 2024
- 204 Pages
Global
From €7149EUR$7,950USD£6,166GBP
- Report
- February 2024
- 360 Pages
Global
From €7149EUR$7,950USD£6,166GBP
- Report
- January 2024
- 171 Pages
Global
From €6745EUR$7,500USD£5,817GBP
- Report
- January 2024
- 200 Pages
Global
From €7149EUR$7,950USD£6,166GBP
- Report
- January 2024
- 174 Pages
Global
From €7149EUR$7,950USD£6,166GBP
- Report
- January 2022
- 200 Pages
Global
From €6745EUR$7,500USD£5,817GBP
- Report
- January 2022
- 60 Pages
Global
From €3552EUR$3,950USD£3,064GBP
- Report
- January 2022
- 60 Pages
Global
From €3552EUR$3,950USD£3,064GBP
- Report
- January 2022
- 200 Pages
Global
From €6745EUR$7,500USD£5,817GBP
- Report
- March 2021
- 149 Pages
Global
From €6250EUR$6,950USD£5,390GBP
- Clinical Trials
- January 2021
- 60 Pages
Global
From €1349EUR$1,500USD£1,163GBP
- Report
- May 2024
- 116 Pages
Global
From €2664EUR$2,963USD£2,298GBP
€3552EUR$3,950USD£3,064GBP
- Report
- May 2024
- 100 Pages
Global
From €2664EUR$2,963USD£2,298GBP
€3552EUR$3,950USD£3,064GBP
- Report
- May 2024
- 145 Pages
Global
From €2664EUR$2,963USD£2,298GBP
€3552EUR$3,950USD£3,064GBP
- Report
- November 2023
- 148 Pages
Global
From €3001EUR$3,338USD£2,588GBP
€4002EUR$4,450USD£3,451GBP
- Report
- March 2022
- 124 Pages
Global
From €3001EUR$3,338USD£2,588GBP
€4002EUR$4,450USD£3,451GBP
- Report
- March 2025
- 181 Pages
Global
From €4047EUR$4,500USD£3,490GBP
- Report
- April 2024
- 115 Pages
Global
From €4047EUR$4,500USD£3,490GBP
- Report
- June 2023
- 111 Pages
Global
From €4047EUR$4,500USD£3,490GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more